CV
Clarus Ventures Portfolio holdings
AUM
$425M
This Quarter Return
-6.21%
1 Year Return
+28.76%
3 Year Return
+73.84%
5 Year Return
+169.94%
10 Year Return
–
AUM
$114M
AUM Growth
+$114M
(-14%)
Cap. Flow
-$9.8M
Cap. Flow
% of AUM
-8.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
|
$9.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
1
DELISTED
NanoString Technologies, Inc.
NSTG
| $49.9M | 43.65% |
3,959,440
| – | – |
|
|
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $19.4M | 16.95% |
2,153,092
| – | – |
|
|
SIEN
3
DELISTED
Sientra, Inc.
SIEN
| $18M | 15.72% |
2,730,765
| – | – |
|
|
VBIV
4
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $10.6M | 9.3% |
2,691,042
-2,481,971
| -48% | -$9.8M |
|
5
Astria Therapeutics
ATXS
$349M
| $10.2M | 8.91% |
2,752,488
| – | – |
|
6
ESSA Pharma
EPIX
$11.4M
| $6.26M | 5.47% |
2,121,212
| – | – |
|